Rezolute, Inc. (RZLT) SEC Filings & Financial Intelligence
Rezolute, Inc. (RZLT) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RZLT
CIK: 1509261
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 06/30
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Grant Thornton LLP
Auditor SinceSince 6/30/2024 12:00:00 AM
Lead Engagement PartnerNiall Fagan
Audit LocationNewport Beach, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| S-3 | 2026-11-05 | — | S-3 | 0001104659-26-123421 | View SEC Doc Filr Page |
| 10-Q | 2026-11-05 | 2026-09-30 | 10-Q | 0001104659-26-123364 | View SEC Doc Filr Page |
| 8-K | 2026-11-05 | 2026-11-05 | FORM 8-K | 0001104659-26-123336 | View SEC Doc Filr Page |
| 8-K | 2026-10-29 | 2026-10-29 | FORM 8-K | 0001104659-26-120205 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-10-28 | — | SCHEDULE 13G Filing | 0000053417-26-000065 | View SEC Doc Filr Page |
| 4 | 2026-10-23 | 2026-10-21 | FORM 4 | 0000912282-26-001376 | View SEC Doc Filr Page |
| DEF 14A | 2026-10-21 | 2026-12-02 | DEF 14A | 0001104659-26-117868 | View SEC Doc Filr Page |
| DRS | 2026-10-15 | — | DRS Filing | 0001104659-26-116249 | View SEC Doc Filr Page |
| 8-K | 2026-10-14 | 2026-10-14 | FORM 8-K | 0001104659-26-115874 | View SEC Doc Filr Page |
| PRE 14A | 2026-10-07 | 2026-12-02 | PRE 14A | 0001104659-26-114396 | View SEC Doc Filr Page |
| 8-K | 2026-10-05 | 2026-10-05 | FORM 8-K | 0001104659-26-113503 | View SEC Doc Filr Page |
| 10-K | 2026-09-24 | 2026-06-30 | 10-K | 0001104659-26-110420 | View SEC Doc Filr Page |
| 8-K | 2026-09-24 | 2026-09-24 | FORM 8-K | 0001104659-26-110412 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-02 | FORM 4 | 0000912282-26-001216 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003436 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-12 | — | SCHEDULE 13G/A Filing | 0000070858-26-000432 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-12 | — | SCHEDULE 13G Filing | 0001943462-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-07-07 | 2026-07-02 | FORM 4 | 0000912282-26-000936 | View SEC Doc Filr Page |
| 4 | 2026-07-07 | 2026-07-02 | FORM 4 | 0000912282-26-000930 | View SEC Doc Filr Page |
| 4 | 2026-07-07 | 2026-07-02 | FORM 4 | 0000912282-26-000929 | View SEC Doc Filr Page |
| 8-K | 2026-06-02 | 2026-06-02 | FORM 8-K | 0001104659-26-069206 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0001193125-26-225186 | View SEC Doc Filr Page |
| 10-Q | 2026-05-12 | 2026-03-31 | 10-Q | 0001104659-26-059422 | View SEC Doc Filr Page |
| 8-K | 2026-05-12 | 2026-05-12 | FORM 8-K | 0001104659-26-059392 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-11 | — | SCHEDULE 13G/A Filing | 0001493152-26-022242 | View SEC Doc Filr Page |